Posted inStock Dow futures slip 214 points amid Fed jitters: 5 things to know before Wall Street opens Dow futures were under pressure on Friday, falling about 214 points, roughly 0.5% as investors… November 14, 2025 Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inPolitics Here’s what happened during Trump’s 14th week in office President Donald Trump is closing in on the first 100 days of his administration this… April 26, 2025
Posted inStock CartelFi price prediction 2025: can it outperform PEPE and Floki? CartelFi is a meme coin project with a DeFi foundation, aiming to transform volatile tokens… April 25, 2025
Posted inStock Europe markets open: stocks gain, tracking global rally; Safran jumps 3% on earnings European stock markets began Friday’s session on a positive note, carrying forward momentum from a… April 25, 2025
Posted inStock Chinese companies look to Southeast Asia for listings amid tariff tensions Chinese companies are increasingly looking to Southeast Asia as a fundraising and listing destination, as… April 25, 2025
Posted inStock Here’s why the Ocado share price may surge despite challenges Ocado share price continues to consolidate near its eight-year low as concerns about its growth… April 25, 2025
Posted inStock Indian markets close: Sensex plunges 589 pts, Nifty closes near 24K; IT bucks trend India’s equity benchmarks snapped their impressive seven-day winning streak on Friday, April 25, closing lower… April 25, 2025
Posted inStock Weak Q2 guidance drags Intel shares; analysts cite tariffs, shrinking market share as ongoing risks Intel Corp (NASDAQ: INTC) forecast lower-than-expected revenue and profit for the second quarter, unsettling investors… April 25, 2025
Posted inStock Should Google consider breaking up? Analyst says it’s the ‘best thing to do’ Alphabet Inc (NASDAQ: GOOGL) has been contending with the Department of Justice over its proposal… April 25, 2025
Posted inStock T-Mobile falls 6% on lagging phone subscriber growth; analysts acknowledge market strength but say TMUS is overvalued T-Mobile US (NASDAQ: TMUS) reported better-than-expected first-quarter earnings on Thursday, but its slower-than-anticipated growth in… April 25, 2025
Posted inStock US stocks off to a muted start: Dow Jones slips 0.2%, Nasdaq flat US stocks opened on a cautious note Friday, barely budging after a strong three-day rally,… April 25, 2025